Your funds, side by side
These are the lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- Virtus Biotech Clinical Trials Etf ETFis Series Trust I · 131 lines · as of Jul 31, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | Virtus Biotech Clinical Trials Etf |
|---|---|
| First Tracks Biotherapeutics Inc | 1.67 % |
| MBX BIOSCIENCES INC | 1.24 % |
| AtaiBeckley Inc | 1.23 % |
| Monopar Therapeutics Inc | 1.21 % |
| Definium Therapeutics Inc | 1.18 % |
| Xencor Inc | 1.10 % |
| ZENAS BIOPHARMA INC | 1.06 % |
| uniQure NV | 1.06 % |
| Apogee Therapeutics Inc | 1.02 % |
| VOR BIOPHARMA INC | 0.99 % |
| REGENXBIO Inc | 0.97 % |
| LB Pharmaceuticals Inc | 0.94 % |
| DAMORA THERAPEUTICS INC | 0.93 % |
| AMYLYX PHARMACEUTICALS INC | 0.93 % |
| DYNE THERAPEUTICS INC | 0.93 % |
| ORUKA THERAPEUTICS INC | 0.93 % |
| Nurix Therapeutics Inc | 0.92 % |
| ORIC Pharmaceuticals Inc | 0.90 % |
| GH RESEARCH PLC | 0.89 % |
| Sionna Therapeutics Inc | 0.88 % |
| Dianthus Therapeutics Inc | 0.87 % |
| Erasca Inc | 0.87 % |
| JADE BIOSCIENCES INC | 0.86 % |
| SELLAS Life Sciences Group Inc | 0.86 % |
| PALVELLA THERAPEUTICS INC | 0.86 % |
| Relay Therapeutics Inc | 0.85 % |
| Replimune Group Inc | 0.85 % |
| Alto Neuroscience Inc | 0.84 % |
| ADLAI NORTYE LTD | 0.84 % |
| Bicara Therapeutics Inc | 0.84 % |
Titelia read 131 lines in these 1 funds.